Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that it will present additional data from the pivotal Phase 3 ...

A Phase III trial evaluating nex-z in transthyretin amyloidosis with cardiomyopathy is underway, with plans for another ...

"I don't agree with every last thing Trump does, but I do agree with what's going to help me be successful in my industries. It's that simple." ...

Most pet insurance companies allow pet parents to enroll their kittens as early as six to eight weeks old. Enrolling your ...

Brandi Muhle was 9 years old when her 35-year-old mother, an Omaha police officer and a marathon runner, was first diagnosed ...

Spinal muscle atrophyorspinal muscular atrophy(SMA) is a genetic disorder that can affect babies, children, and adults. A ...

Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit offers insight into the new NCCN guidelines, discusses the new ...

Richard Geary; Executive Vice President, Chief Development Officer; Ionis Pharmaceuticals Inc Elizabeth Hougen; Chief Financial Officer, Executive Vice President - Finance; Ionis Pharmaceuticals Inc ...

As the Section 2 boys’ basketball tournament begins on Friday, BKW is the clear favorite in Class C, a 20-0 No. 1 seed that ...

When symptoms such as "noticing significant developmental delays in mobility, language, and social interaction since age two" are entered into a dialogue box, an AI large model can generate alerts ...

Researchers at Vilnius University have developed an effective approach to liquid biopsy that contributes to the field of ...